We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Clinical Laboratory Segment in China Is Thriving

By LabMedica International staff writers
Posted on 01 Jun 2009
Healthcare spending despite the global recession, expands the clinical lab market in China.

A report by Kalorama Information (Rockville, MD, USA), published in partnership with healthcare IVD market research firm McEvoy & Farmer (Seattle, WA, USA; http://mcevoyandfarmer.com) claims that China's economic growth is estimated by nongovernmental sources to be even higher than the government's official report of about 10%. More...
The country is urbanizing and modernizing and the greater levels of prosperity will enable citizens to seek improved health care and diagnostics.

The Kalorama report forecasts that IVD markets in China will grow to more than $1.5 billion in 2009, making it the world's sixth largest IVD market. The last few years have seen market growth of 15-20%. Approximately 575 new hospitals open in China each year and the government plans to open more than 20,000 health clinics.

In January 2009, China's State Council announced a new US$123 billion healthcare spending program to bring a minimum standard of medical insurance coverage to 90% of entire population. The plan also aims to upgrade hospitals and improve health centers in rural and remote areas. This will result in an increased demand for small instrument placements at thousands of clinics and health centers across the country. China is already the world's number two market for automated IVD instrumentation. Now a significant but completely new market for smaller, more robust instrumentation is emerging.

Kalorama Information is a provider of market research reports for diagnostics, pharmaceutics, medical devices, biotechnology and healthcare. McEvoy and Farmer focus on a single sector of the economy--the IVD marketplace. The company specializes in the emerging markets of Asia and Latin America.

Related Links:

Kalorama Information
McEvoy & Farmer



Gold Member
Automatic Hematology Analyzer
CF9600
Online QC Software
Acusera 24•7
New
Prefilled Tubes
Prefilled 5.0ml Tubes
New
Clinical Informatics Platform
CLARION™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: For decades, laboratories have adjusted total calcium for albumin, but growing evidence shows these corrections often perform poorly and may cause harm (image credit: iStock)

International Experts Recommend Ending Routine 'Corrected' Calcium Reporting

Interpreting serum calcium can be clinically challenging when albumin levels vary, especially in patients with chronic illness or kidney disease. For decades, laboratories have used formulas to adjust... Read more

Molecular Diagnostics

view channel
Image: The integrated multi-omics approach may help identify bladder cancer patients likely to respond to BCG and those needing alternative or intensified treatment (image credit: iStock)

Multi-Omics Profiling Helps Predict BCG Response and Recurrence in Bladder Cancer

High-risk non–muscle-invasive bladder cancer frequently recurs after therapy, with about 30% of patients relapsing and roughly 10% dying within two years despite tumor resection, surveillance, and Bacillus... Read more

Microbiology

view channel
Image: The findings suggest that people with mpox can transmit the virus even without clinical symptoms (image credit: Adobe Stock)

Study Finds Hidden Mpox Infections May Drive Ongoing Spread

Mpox continues to circulate despite vaccination, and many cases show no known link to a symptomatic partner. The role of people without symptoms has remained uncertain, limiting clarity on how transmission persists.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.